Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

Clinical trial NCT06594068 · RECRUITING

Trial details

NCT number: NCT06594068
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2026-01-16
Primary completion: 2027-08-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.